Relypsa Up 10% Following Encouraging Phase 1 Study Results
January 26, 2016 at 08:30 AM EST
Shares of Relypsa Inc (NASDAQ: RLYP), a biopharmaceutical company that focuses on non-absorbed polymeric drugs to tread disorders in the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
